Shunbin Xiong

3.4k total citations
47 papers, 2.5k citations indexed

About

Shunbin Xiong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shunbin Xiong has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 32 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Shunbin Xiong's work include Cancer-related Molecular Pathways (26 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (11 papers). Shunbin Xiong is often cited by papers focused on Cancer-related Molecular Pathways (26 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (11 papers). Shunbin Xiong collaborates with scholars based in United States, China and France. Shunbin Xiong's co-authors include Guillermina Lozano, Tianyang Mu, Guowen Wang, Xuejun Jiang, Dihua Yu, Vinod Pant, Carolyn S. Van Pelt, Raphael E. Pollock, John M. Parant and Salih J. Wakil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Shunbin Xiong

46 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunbin Xiong United States 26 1.6k 1.2k 619 282 205 47 2.5k
Gianluca Bossi Italy 30 1.4k 0.8× 988 0.8× 547 0.9× 192 0.7× 160 0.8× 53 2.2k
Sagar Sengupta India 27 2.2k 1.3× 1.0k 0.8× 574 0.9× 146 0.5× 124 0.6× 60 2.9k
Alessandro Rufini United Kingdom 19 1.7k 1.0× 1.0k 0.9× 600 1.0× 109 0.4× 303 1.5× 29 2.4k
Masahiro Hitomi United States 30 2.1k 1.3× 1.2k 1.0× 632 1.0× 188 0.7× 118 0.6× 65 3.0k
Shizuka Seino Japan 26 1.4k 0.8× 614 0.5× 457 0.7× 146 0.5× 149 0.7× 44 2.0k
Thomas Ludwig United States 31 2.5k 1.6× 1.5k 1.2× 670 1.1× 205 0.7× 121 0.6× 45 3.5k
Rieko Ohki Japan 21 2.3k 1.4× 1.2k 1.0× 445 0.7× 135 0.5× 213 1.0× 50 3.0k
Zoya N. Demidenko United States 32 2.5k 1.6× 1.0k 0.8× 622 1.0× 192 0.7× 156 0.8× 41 3.8k
Andrea Sacchetti Netherlands 25 1.2k 0.7× 821 0.7× 401 0.6× 176 0.6× 88 0.4× 50 2.4k

Countries citing papers authored by Shunbin Xiong

Since Specialization
Citations

This map shows the geographic impact of Shunbin Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunbin Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunbin Xiong more than expected).

Fields of papers citing papers by Shunbin Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunbin Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunbin Xiong. The network helps show where Shunbin Xiong may publish in the future.

Co-authorship network of co-authors of Shunbin Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Shunbin Xiong. A scholar is included among the top collaborators of Shunbin Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunbin Xiong. Shunbin Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Shunbin, Yun Zhang, Xin Zhou, et al.. (2025). Dependence on Mdm2 for Mdm4 inhibition of p53 activity. Cancer Letters. 621. 217622–217622.
2.
Dibra, Denada, Shunbin Xiong, Sydney M. Moyer, et al.. (2024). Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Science Advances. 10(7). eadk1835–eadk1835. 22 indexed citations
3.
Dibra, Denada, Lalit R. Patel, Shunbin Xiong, et al.. (2024). p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator. Cancer Research Communications. 4(8). 1991–2007. 1 indexed citations
4.
Xiong, Shunbin, Dhruv Chachad, Yun Zhang, et al.. (2022). Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo. Cancer Research. 82(10). 1926–1936. 29 indexed citations
5.
Yu, Xiaojie, Yun Zhang, Shunbin Xiong, et al.. (2022). Omics analyses of a somaticTrp53R245W/+breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling. Proceedings of the National Academy of Sciences. 119(45). 13 indexed citations
6.
Xiong, Yuqing, et al.. (2020). A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer. Biology. 9(9). 285–285. 33 indexed citations
7.
Guo, Xu, Yao Xu, Xin Wang, et al.. (2019). Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation. Medical Science Monitor. 25. 1105–1112. 21 indexed citations
8.
9.
Zhang, Yanqin, Qianghua Hu, Lili Li, et al.. (2018). ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway. Cellular Physiology and Biochemistry. 48(3). 1099–1111. 20 indexed citations
10.
Post, Sean M., Vinod Pant, Shunbin Xiong, et al.. (2017). Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes. Oncogene. 37(3). 332–340. 8 indexed citations
11.
Pant, Vinod, Shunbin Xiong, Gilda P. Chau, et al.. (2016). Distinct downstream targets manifest p53-dependent pathologies in mice. Oncogene. 35(44). 5713–5721. 17 indexed citations
12.
Zhang, Yun, et al.. (2015). p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis. Molecular Cancer Research. 14(1). 56–65. 6 indexed citations
13.
Mancini, Francesca Romana, Luisa Pieroni, Rossella Lucà, et al.. (2015). MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response. Oncogene. 35(2). 228–240. 34 indexed citations
14.
Li, Qin, Yun Zhang, Adel K. El‐Naggar, et al.. (2014). Therapeutic Efficacy of p53 Restoration in Mdm2 -Overexpressing Tumors. Molecular Cancer Research. 12(6). 901–911. 25 indexed citations
15.
Xiong, Shunbin. (2013). Mouse models of Mdm2 and Mdm4 and their clinical implications. Chinese Journal of Cancer. 32(7). 371–375. 16 indexed citations
16.
Wang, Yongxing, Young‐Ah Suh, James G. Jackson, et al.. (2011). Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. Journal of Clinical Investigation. 121(3). 893–904. 106 indexed citations
17.
Xiong, Shunbin, Vinod Pant, Young‐Ah Suh, et al.. (2010). Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4. Cancer Research. 70(18). 7148–7154. 59 indexed citations
18.
Lin, Patrick P., et al.. (2008). EWS-FLI1 Induces Developmental Abnormalities and Accelerates Sarcoma Formation in a Transgenic Mouse Model. Cancer Research. 68(21). 8968–8975. 72 indexed citations
19.
Terzian, Tamara, et al.. (2007). The p53–Mdm2 network in progenitor cell expansion during mouse postnatal development. The Journal of Pathology. 213(4). 360–368. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Bossi Breakdown of academic impact, for papers by Sagar Sengupta Breakdown of academic impact, for papers by Alessandro Rufini Breakdown of academic impact, for papers by Masahiro Hitomi Breakdown of academic impact, for papers by Shizuka Seino Breakdown of academic impact, for papers by Thomas Ludwig Breakdown of academic impact, for papers by Rieko Ohki Breakdown of academic impact, for papers by Zoya N. Demidenko Breakdown of academic impact, for papers by Andrea Sacchetti
Rankless by CCL
2026